Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark P Nicol

Showing results (1-10 of 215) with videos related to

Pageof 22
Sort By:
The Lancet. Respiratory Medicine|January 17, 2014
Xpert MTB/RIF: monitoring response to tuberculosis treatmentMark P Nicol
Expert Review of Molecular Diagnostics|November 9, 2016
How should tuberculosis molecular diagnostics be adapted for use in seriously ill HIV patients?Mark P Nicol
The Lancet. Infectious Diseases|December 11, 2017
Tuberculosis eradication: renewed commitment and global investment requiredHelen Cox, Mark P Nicol
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2021
A Novel Bedside Rule-in Test for Tuberculous Meningitis in Human Immunodeficiency Virus-Infected AdultsTobias Broger, Mark P Nicol
Transactions of the Royal Society of Tropical Medicine and Hygiene|June 3, 2008
The clinical consequences of strain diversity in Mycobacterium tuberculosisMark P Nicol, Robert J Wilkinson
Pediatrics|October 27, 2019
Strengthening Diagnosis of Pulmonary Tuberculosis in Children: The Role of Xpert MTB/RIF UltraHeather J Zar, Mark P Nicol
Future Microbiology|October 1, 2011
Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistanceStephen D Lawn, Mark P Nicol
Paediatric Respiratory Reviews|December 22, 2010
New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospectsMark P Nicol, Heather J Zar
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2007
Evidence guiding the treatment of children with mycobacterial diseasesMark P Nicol, Robert J Wilkinson
Lancet (London, England)|September 23, 2018
Treatment of bronchiectasis exacerbations in children: which antibiotic?Heather J Zar, Mark P Nicol
Pageof 22

Showing results (1-10 of 215) with videos related to

Sort By:
Pageof 22
The Lancet. Respiratory Medicine|January 17, 2014
Xpert MTB/RIF: monitoring response to tuberculosis treatmentMark P Nicol
Expert Review of Molecular Diagnostics|November 9, 2016
How should tuberculosis molecular diagnostics be adapted for use in seriously ill HIV patients?Mark P Nicol
The Lancet. Infectious Diseases|December 11, 2017
Tuberculosis eradication: renewed commitment and global investment requiredHelen Cox, Mark P Nicol
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 6, 2021
A Novel Bedside Rule-in Test for Tuberculous Meningitis in Human Immunodeficiency Virus-Infected AdultsTobias Broger, Mark P Nicol
Transactions of the Royal Society of Tropical Medicine and Hygiene|June 3, 2008
The clinical consequences of strain diversity in Mycobacterium tuberculosisMark P Nicol, Robert J Wilkinson
Pediatrics|October 27, 2019
Strengthening Diagnosis of Pulmonary Tuberculosis in Children: The Role of Xpert MTB/RIF UltraHeather J Zar, Mark P Nicol
Future Microbiology|October 1, 2011
Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistanceStephen D Lawn, Mark P Nicol
Paediatric Respiratory Reviews|December 22, 2010
New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospectsMark P Nicol, Heather J Zar
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2007
Evidence guiding the treatment of children with mycobacterial diseasesMark P Nicol, Robert J Wilkinson
Lancet (London, England)|September 23, 2018
Treatment of bronchiectasis exacerbations in children: which antibiotic?Heather J Zar, Mark P Nicol
Pageof 22